Hagai Tavori Selected Research

Hagai Tavori Research Topics

Disease

10	Atherosclerosis 01/2022 - 03/2009
7	Inflammation (Inflammations) 01/2022 - 10/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2019 - 10/2014
3	Hypercholesterolemia 01/2019 - 04/2015
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2019 - 12/2013
2	Hypertension (High Blood Pressure) 11/2021 - 05/2012
2	Insulin Resistance 11/2021 - 10/2021
2	Dyslipidemias (Dyslipidemia) 11/2021 - 10/2014
2	Atherosclerotic Plaque (Atheroma) 10/2018 - 03/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2021
1	Hyperlipidemias (Hyperlipidemia) 11/2021
1	Obesity 11/2021
1	Maternal Obesity 10/2021
1	Chest Pain (Chest Pains) 09/2021
1	Pathologic Constriction (Stenosis) 09/2021
1	Myocardial Infarction 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2021
1	Stroke (Strokes) 01/2021
1	Smoldering Multiple Myeloma 05/2020
1	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 11/2017
1	Pancreatitis 11/2017
1	2 Familial Hypobetalipoproteinemia 01/2017
1	Hypobetalipoproteinemias (Hypobetalipoproteinemia) 01/2017
1	Dermatitis 03/2015
1	Wounds and Injuries (Trauma) 11/2014
1	Tomaculous neuropathy 11/2014
1	Lipoprotein Glomerulopathy 10/2014
1	Coronary Disease (Coronary Heart Disease) 07/2014
1	Hypertriglyceridemia 07/2014
1	Abdominal Aortic Aneurysm 01/2014
1	Hypotension (Low Blood Pressure) 05/2012

Drug/Important Bio-Agent (IBA)

6	Lipoproteins (Lipoprotein)IBA 01/2019 - 12/2013
6	CholesterolIBA 10/2018 - 01/2014
5	Proprotein Convertase 9IBA 11/2018 - 07/2014
4	Apolipoproteins E (ApoE)IBA 01/2022 - 10/2014
4	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2022 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 10/2021 - 03/2015
4	LDL Lipoproteins (beta Lipoproteins)IBA 01/2016 - 03/2009
3	LDL Receptors (LDL Receptor)IBA 01/2021 - 07/2014
3	LDL CholesterolIBA 01/2019 - 07/2014
3	oxidized low density lipoproteinIBA 01/2017 - 12/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2016
2	CC ChemokinesIBA 01/2019 - 10/2018
2	ApolipoproteinsIBA 01/2017 - 07/2014
2	Apolipoproteins B (ApoB)IBA 01/2017 - 07/2014
2	LipidsIBA 05/2016 - 03/2009
2	Angiotensin IIIBA 01/2014 - 05/2012
2	Aryldialkylphosphatase (Paraoxonase)IBA 05/2012 - 03/2009
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Plasminogen Activator Inhibitor 1IBA 11/2021
1	Insulin (Novolin)FDA Link 10/2021
1	Sirtuin 3IBA 10/2021
1	regadenoson FDA Link 09/2021
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2021
1	ISIS 416858IBA 01/2021
1	AntibodiesIBA 01/2021
1	cadherin 5IBA 01/2021
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2021
1	Kininogens (Kininogen)IBA 01/2021
1	PrekallikreinIBA 01/2021
1	von Willebrand FactorIBA 10/2020
1	AutoantibodiesIBA 05/2020
1	HDL CholesterolIBA 05/2020
1	Lipoprotein(a)IBA 10/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 11/2017
1	Fish OilsIBA 11/2017
1	Fibric Acids (Fibrates)IBA 11/2017
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 11/2017
1	Apolipoprotein C-II (ApoC2)IBA 11/2017
1	Orlistat (Xenical)FDA Link 11/2017
1	FurinIBA 01/2017
1	AngiopoietinsIBA 01/2017
1	Adalimumab (Humira)FDA Link 01/2016
1	Blood Proteins (Serum Proteins)IBA 04/2015
1	Myelin ProteinsIBA 11/2014
1	Apolipoprotein E2IBA 10/2014
1	Apolipoprotein E3IBA 10/2014
1	Triglycerides (Triacylglycerol)IBA 07/2014
1	AngiotensinsIBA 01/2014
1	AcidsIBA 05/2012
1	AldosteroneIBA 05/2012
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 05/2012
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2012
1	AntioxidantsIBA 03/2009

Therapy/Procedure

4	Therapeutics 01/2021 - 07/2014
2	Blood Component Removal (Apheresis) 01/2019 - 12/2013